We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Association of the British Pharmaceutical Industry (ABPI) has suspended Merck Sharp & Dohme (MSD) for at least three months for violations of the industry group’s code of ethics.
Starting in January 2007, pharmaceutical and medical device manufacturers, as well as other importers and exporters, will need a special security certificate in order to move freely through the European Union (EU) market.
Starting in January 2007, every medical device and pharmaceutical manufacturer, as well as other importers and exporters, will need a special security certificate to move products freely through the EU market.
The European Medicines Agency (EMEA) has released guidance on phasing in European Commission decisions concerning centrally authorized products (CAPs) in Bulgaria and Romania.
Merck’s cervical cancer vaccine Gardasil is one step closer to being approved for use in the EU after getting a positive opinion from the Committee for Medicinal Products for Human Use on July 28.
The European Medicines Agency (EMEA) has issued separate guidelines on clinical investigations of medicinal products used in the treatment of sepsis and weight control, as well as two other major medical conditions.
The Council of the European Union (EU), meeting June 27 in Luxembourg, adopted its common position on proposed legislation for the Registration, Evaluation and Authorization of Chemicals (REACH) used in human medicines.
The European Medicines Agency (EMEA) has introduced new procedures designed to streamline the way the agency provides scientific advice on investigational medicines and help move them more quickly from the laboratory to the marketplace.
Under new regulations passed by the European Parliament, drug companies that research the safety and efficacy of their products in children will get a six-month patent extension.